Skip to main content

Table 1 Baseline characteristics and comparison of survivors and non-survivors

From: Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry

Variable

Overall

Died

Survived

P value

Number of patients

2699

1582

1117

 

Days of ECMO (median (IQR))

4.00 (1.96, 6.83)

3.83 (1.67, 7.00)

4.13 (2.46, 6.67)

0.002

Age (years) (median (IQR))

54.0 (42.0, 63.0)

56.0 (44.0, 65.0)

52.0 (38.0, 61.0)

<0.001

Sex (%)

   

0.341

Female

862 (31.9)

522 (33.0)

340 (30.4)

 

Male

1815 (67.2)

1048 (66.2)

767 (68.7)

 

Weight (kg) (median (IQR))

75.0 (64.0, 88.9)

76.0 (63.7, 90.0)

75.0 (64.1, 86.0)

0.138

Intubation to ECMO (median (IQR))a

10.0 (4.0, 25.0)

12.0 (5.0, 31.0)

8.5 (3.0, 22.0)

<0.001

pH (median (IQR))

7.31 (7.21, 7.40)

7.30 (7.19, 7.39)

7.32 (7.23, 7.40)

0.001

Bicarbonate (mmol/l) (median (IQR))

20.0 (16.3, 23.1)

19.2 (15.4, 23.0)

20.6 (17.3, 24.0)

<0.001

MAP (mmHg) (median (IQR))

59 (49, 70)

57 (47, 68)

62 (51, 72)

<0.001

  1. aNumber of hours from endotracheal intubation to initiation of extracorporeal membrane oxygenation (ECMO). Sex not specified in 22 cases. pH, bicarbonate and mean arterial blood pressure (MAP) were all measured prior to initiation of ECMO. IQR interquartile range